CORRESP Filing
ADIAL PHARMACEUTICALS, INC.
Date: June 12, 2025 · CIK: 0001513525 · Accession: 0001213900-25-053826
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287826
Letter
VIA EDGAR United States Securities Division of Corporation Finance Attention: Doris Stacy Gama Re: Adial Pharmaceuticals, Inc. Registration Statement on Form S-1 Filed June 6, 2025 File No: 333-287826
Dear Ms. Gama:
Reference is made to our letter, filed as correspondence via EDGAR on June 6, 2025, requesting acceleration of effectiveness of the above-referenced Registration Statement for Tuesday, June 10, 2025 at 9:00 a.m. Eastern Time, which was amended via telephone and email to Wednesday , June 12, 2025 at 5:00 p.m.
We are no longer requesting that such Registration Statement be declared effective at the time mentioned above, and we hereby formally withdraw our request for acceleration of the above referenced effective date.
Very truly yours,
ADIAL PHARMACEUITCALS, INC.
Show Raw Text
CORRESP 1 filename1.htm June 12, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Stacy Gama Re: Adial Pharmaceuticals, Inc. Registration Statement on Form S-1 Filed June 6, 2025 File No: 333-287826 Dear Ms. Gama: Reference is made to our letter, filed as correspondence via EDGAR on June 6, 2025, requesting acceleration of effectiveness of the above-referenced Registration Statement for Tuesday, June 10, 2025 at 9:00 a.m. Eastern Time, which was amended via telephone and email to Wednesday , June 12, 2025 at 5:00 p.m. We are no longer requesting that such Registration Statement be declared effective at the time mentioned above, and we hereby formally withdraw our request for acceleration of the above referenced effective date. Very truly yours, ADIAL PHARMACEUITCALS, INC. By: /s/ Cary Claiborne Name: Cary Claiborne Title: Chief Executive Officer cc: Leslie Marlow, Blank Rome LLP